Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Core EBITDA Growth

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 18.3121.3829.11-12.9944.86

What is the latest Core EBITDA Growth ratio of CONCORD BIOTECH ?

The latest Core EBITDA Growth ratio of CONCORD BIOTECH is 18.31 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202518.31
Mar202421.38
Mar202329.11
Mar2022-12.99
Mar202144.86

How is Core EBITDA Growth of CONCORD BIOTECH Trending?

Years Core EBITDA Growth % Change
Mar2025 18.31
-14.36
Mar2024 21.38
-26.55
Mar2023 29.11
Positive
Mar2022 -12.99
Negative
Mar2021 44.86 -

Other Financial Ratios of CONCORD BIOTECH


Compare Core EBITDA Growth ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹16,965.6 Cr -0.9% -8.1% -28.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,368.0 Cr 0.7% -0.7% -11% Stock Analytics
DIVIS LABORATORIES ₹160,631.0 Cr NA -1.6% 12.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,641.0 Cr 3.1% -0.9% 9.1% Stock Analytics
CIPLA ₹123,419.0 Cr -2% -4% -5.9% Stock Analytics
DR REDDYS LABORATORIES ₹109,176.0 Cr -0.2% 2.4% 0% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-0.9%

-8.1%

-28.2%

SENSEX

-0.3%

0.1%

-1%


You may also like the below Video Courses